Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUP160 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HNRNPC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SERP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPATS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALG8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRTFDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SDR39U1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNAI3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AACS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNAS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACKR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAI14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FLI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RCN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC16A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on